Certara appoints patrick f. smith to president of integrated drug development

Princeton, n.j., oct. 12, 2021 (globe newswire) -- certara, inc. (nasdaq: cert), a global leader in biosimulation, today announced the appointment of patrick f. smith, pharm.d. as president of integrated drug development (idd), reporting to ceo william f. feehery. dr. smith will lead the company's global drug development services team, which creates value for clients across the entire drug development life cycle using biosimulation and quantitative approaches. dr. smith succeeds craig r. rayner, pharm.d., who has served as president of idd since 2019 and will be appointed to the role of certara distinguished scientist, leading key strategic client engagements and scientific innovation.
CERT Ratings Summary
CERT Quant Ranking